Loading…
Loading…
Received First LockeT Purchase Order Through Cardinal Health which serves approximately 90% of U.S. Hospitals though its Medical Products business
New Account Creation Increased 170% During the First 17 Days of August Compared to the Same Period in July Flyte Has Added More Accounts Since July 1 Than During the Entire First Half of 2026 Growing First-Party Customer Base Now Spans 174 Airports Across 19 States FORT MILL, S.C., Aug. 20, 2026 (GLOBE NEWSWIRE) -- Flyte, a subsidiary of Catheter Precision, Inc. (NYSE American: VTAK) (“VTAK” or the “Company”), today announced that more than 10,000 consumer accounts are now registered on the Flyte WebApp, marking a significant milestone as new account creation continues to accelerate across the Company's technology-enabled private aviation platform.
Strategic Partnership Positions Flyte as the Premier Regional Aviation Solution for Statewide Campaigns While Expanding Access to More Than 5,000 Candidates, SuperPACs and Political Organizations
Strategic Partnership Places Flyte at the Center of One of the Nation's Premier Communities of Founders, Investors, and Operators Collaboration Reflects Flyte's Continued Commitment to Building Relationships Within the Entrepreneurial and Venture Capital Ecosystem FORT MILL, S.C., Aug. 11, 2026 (GLOBE NEWSWIRE) -- Flyte, a subsidiary of Catheter Precision, Inc. (NYSE American: VTAK) ("VTAK" or the "Company"), today announced a strategic partnership with The Nucleus Network, a rapidly growing community connecting founders, investors, executives, and innovators, to support the inaugural "The Nucleus" event taking place August 15th at 4:00 p.m.
July 2026 Revenue Increased 102% sequential July Over June to Approximately $640,000 Retail Platform, Strategic Partnerships and Influencer Marketing Fuel Accelerating Growth FORT MILL, S.C., Aug. 06, 2026 (GLOBE NEWSWIRE) -- Flyte, a subsidiary of Catheter Precision, Inc. (NYSE American: VTAK) (“VTAK”), today announced record monthly revenue for July 2026, marking the strongest operating month in Flyte's history as demand continues to accelerate across its private aviation platform.
Enterprise Artificial Intelligence Deployment Expected to Enhance Customer Experience, Improve Operating Efficiency, and Increase Workforce Productivity Across Flight Operations Technology Strengthens Flyte's Scalable Regional Air Mobility Platform Through Intelligent Automation, Operational Excellence, and Long-Term Growth Initiatives FORT MILL, S.C., Aug. 04, 2026 (GLOBE NEWSWIRE) -- Catheter Precision, Inc. (NYSE American: VTAK) (“Catheter Precision” or the “Company”), through its wholly owned subsidiary Flyte, today announced that Flyte has become the inaugural enterprise customer of Volato AI (NYSE American: SOAR), a purpose-built enterprise artificial intelligence platform designed specifically for business aviation.
ATLANTA--(BUSINESS WIRE)--Volato Group, Inc. (NYSE American: SOAR) (“Volato” or the “Company”) today announced the commercial launch and first enterprise deployment of Volato AI, its purpose-built enterprise artificial intelligence platform for business aviation. Flyte, a technology-enabled regional air mobility company owned by Catheter Precision, Inc. (NYSE American: VTAK), will serve as the platform's inaugural enterprise customer. Volato remains principally focused on advancing its previous.
Exclusive Partnership Offers The Maidstone Guests Access and Savings on Flyte's Private Travel Services Collaboration Marks the Beginning of a Long-Term Relationship Connecting Luxury Hospitality with Modern Private Aviation FORT MILL, S.C., July 29, 2026 (GLOBE NEWSWIRE) -- Flyte, a subsidiary of Catheter Precision, Inc. (NYSE American: VTAK) ("VTAK" or the "Company"), today announced a strategic partnership with The Maidstone, one of the Hamptons' most iconic luxury boutique hotels, bringing Flyte's private aviation experience directly to The Maidstone's guests.